Tumor necrosis factor blockers in rheumatoid arthritis.
Publication
, Journal Article
Pisetsky, DS
Published in: The New England journal of medicine
March 2000
Duke Scholars
Published In
The New England journal of medicine
DOI
EISSN
1533-4406
ISSN
0028-4793
Publication Date
March 2000
Volume
342
Issue
11
Start / End Page
810 / 811
Related Subject Headings
- Tumor Necrosis Factor-alpha
- Receptors, Tumor Necrosis Factor
- Infliximab
- Immunoglobulin G
- Humans
- General & Internal Medicine
- Etanercept
- Child
- Arthritis, Juvenile
- Antirheumatic Agents
Citation
APA
Chicago
ICMJE
MLA
NLM
Pisetsky, D. S. (2000). Tumor necrosis factor blockers in rheumatoid arthritis. The New England Journal of Medicine, 342(11), 810–811. https://doi.org/10.1056/nejm200003163421110
Pisetsky, D. S. “Tumor necrosis factor blockers in rheumatoid arthritis.” The New England Journal of Medicine 342, no. 11 (March 2000): 810–11. https://doi.org/10.1056/nejm200003163421110.
Pisetsky DS. Tumor necrosis factor blockers in rheumatoid arthritis. The New England journal of medicine. 2000 Mar;342(11):810–1.
Pisetsky, D. S. “Tumor necrosis factor blockers in rheumatoid arthritis.” The New England Journal of Medicine, vol. 342, no. 11, Mar. 2000, pp. 810–11. Epmc, doi:10.1056/nejm200003163421110.
Pisetsky DS. Tumor necrosis factor blockers in rheumatoid arthritis. The New England journal of medicine. 2000 Mar;342(11):810–811.
Published In
The New England journal of medicine
DOI
EISSN
1533-4406
ISSN
0028-4793
Publication Date
March 2000
Volume
342
Issue
11
Start / End Page
810 / 811
Related Subject Headings
- Tumor Necrosis Factor-alpha
- Receptors, Tumor Necrosis Factor
- Infliximab
- Immunoglobulin G
- Humans
- General & Internal Medicine
- Etanercept
- Child
- Arthritis, Juvenile
- Antirheumatic Agents